Predicting Response to Treatment in Gastroesophageal Junction Adenocarcinomas: Combining Clinical, Imaging, and Molecular Biomarkers

The incidence of adenocarcinomas of the gastroesophageal junction (GEJ) is rapidly rising, and even in early-stage locoregional confined disease the 5-year survival rate rarely exceeds 25%–35%. Randomized trials and meta-analyses have demonstrated a benefit with neoadjuvant or perioperative chemothe...

Full description

Saved in:
Bibliographic Details
Main Authors: Bain, Gillian H., Petty, Russell D.
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2010
Subjects:
Gastrointestinal Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227948/
https://ncbi.nlm.nih.gov/pubmed/20203174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0293
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items